Compare Nuwellis Inc (NUWE) vs Target Corporation (TGT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Target Corporation — how do they compare? Nuwellis Inc trades at $0.79 (market cap $2.54M), while Target Corporation trades at $157.81 (market cap $71.56B). The key difference: Target Corporation is far larger — about 28173.2× Nuwellis Inc's market cap, and Target Corporation pays a 2.95% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| NUWE | TGT | |
|---|---|---|
Market Cap | $2.54M | $71.56B |
Sector | Technology | Consumer Cyclical |
52-Week High | $164.50 | $169.90 |
52-Week Low | $0.73 | $83.68 |
Enterprise Value | -$1.17M | $84.84B |
Dividend Yield | — | 2.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.7878, up 0.88% on the day, with a bearish technical signal despite oversold RSI readings. The company shows revenue growth but deep losses, with a net income margin of -125.63% in 2026. Recent developments include a reverse stock split, leadership changes, and strategic expansions in pediatric care, supported by positive gross margin improvements and new partnerships.
Outlook remains speculative; growth opportunities exist in market expansion and product development, but high cash burn, negative profitability, and reliance on financing pose significant risks. Analyst sentiment is mixed, with equal buy/hold ratings, reflecting uncertainty about the path to profitability.
Target (TGT) trades at $162.71, down 1.05% today, with a bullish technical signal from moving averages and neutral oscillators. The stock shows strong profitability with a 26.41% ROE and 4.08% net margin, supported by three consecutive quarterly EPS beats. Revenue remains stable near $107B, while valuation ratios like P/E of 16.88 and P/S of 0.69 suggest reasonable pricing. Recent news highlights CEO Michael Fiddelke's turnaround success, with shares surging over 70% year-to-date.
Outlook is positive with analyst consensus at $166.67 and 47% buy ratings, but risks include competitive retail pressures and margin compression. The dividend yield of approximately 2.85% adds income appeal, though valuation expansion from recent gains warrants caution amid economic uncertainty.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Target Corporation
With 1,926 stores (as of the end of fiscal 2021), Target is a leading American general merchandise retailer, offering a variety of products across several categories, including beauty and household essentials (26% of fiscal 2021 sales), food and beverage (19%), home furnishings and décor (19%), hardlines (18%), and apparel and accessories (17%). Most of Target's stores are large, averaging more than 125,000 square feet. The company has a significant e-commerce presence, deriving around 19% of sales from the channel (up from about 9% in fiscal 2019, before the pandemic). In addition to its namesake stores, Target owns Shipt, an online same-day delivery platform. After it exited Canada in 2015, virtually all of Target's revenue is generated from the United States.
Read more on TGT →
